Zobrazeno 1 - 10
of 27
pro vyhledávání: '"C.-J. Lindén"'
Publikováno v:
Acta Radiologica. 32:178-181
In order to make electrolytic tumor destruction more effective new electrode materials were tested (Part I) as well as a combination of electrolysis and megavolt therapy (Part II). All tests were performed in experimental tumors implanted subcutaneou
Autor:
G Westman, M Andersson, Bengt Bergman, L Thaning, A Straumits, G Gustavsson, O Birck, M Albertsson, B Jeppson, L Hafström, C.-J Lindén, P Orgum, C Mercke, Sven-Börje Ewers, H Andersson, L Kadar
Publikováno v:
European journal of cancer (Oxford, England : 1990). 35(4)
A randomised double-blind placebo-controlled multicentre trial was performed to investigate the effects of megestrol acetate (MA) on the quality of life (QoL), appetite, weight and survival of patients with advanced, incurable, hormone-insensitive ca
Publikováno v:
European journal of cancer (Oxford, England : 1990). (11)
The aim of this randomised trial was to investigate the effect of induction chemotherapy before radiotherapy on survival in 302 patients with non-resectable squamous cell carcinoma of the lung. Radiotherapy, 56 Gy to the chest, was given to 154 patie
Autor:
C J, Lindén
Publikováno v:
In vivo (Athens, Greece). 5(4)
A human pleural mesothelioma tumour line (AKG) serially transplantable as a subcutaneously growing xenograft in athymic rats was evaluated for chemosensitivity to six antitumour drugs. Drug effects were assessed as the reduction of the area under the
Autor:
C J, Lindén
Publikováno v:
In vivo (Athens, Greece). 4(1)
The effect of doxorubicin (DOX) and cyclophosphamide (CYC) on human pleural mesothelioma AKG was evaluated clinically and compared to the response of the same tumour as a xenograft in athymic rats. The response of the xenograft to each of the drugs w
Publikováno v:
Praxis und Klinik der Pneumologie. 37
Autor:
C J Lindén, L Johansson
Publikováno v:
British Journal of Cancer
A human malignant pleural mesothelioma was xenografted serially in athymic nude Rowett rats for 27 passages during 33 months. After the two initial passages (P), the take rate during P3-9 was 100% (192/192). The tumour grew progressively during P3-9
Publikováno v:
Lakartidningen. 86(15)
Primary and secondary malignant tumours in the central airways can cause obstruction or chronic haemoptyses. Conventional forms of treatment are insufficient. Bronchoscopic Neodymium-YAG laser treatment, hitherto unused in Sweden, can give immediate
Publikováno v:
Nordisk medicin. 100(4)
Publikováno v:
Praxis und Klinik der Pneumologie. 37